©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 110993
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.110993
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.110993
Table 2 Treatment characteristics of the study group, n (%)
| Treatment characteristics | Value (n = 30) | |
| Dose fractionation | ||
| 30 Gy/6 # | 1(3.3) | |
| 30 Gy/5 # | 4 (13.3) | |
| 50 Gy/5 # | 5 (16.7) | |
| 40 Gy/5 # | 6 (20) | |
| 48 Gy/4 # | 1 (13.3) | |
| 35 Gy/5 # | 6 (20) | |
| 33 Gy/6 # | 1(3.3) | |
| 36 Gy/3 # | 3 (10) | |
| 48 Gy/6 # | 1(3.3) | |
| 45 Gy/5 # | 2 (6.7) | |
| Treatment volumes | ||
| GTV diameter (median cm) (range) | 6.1 (2.54-10.63) | |
| GTV volume (median cc) (range) | 49.05 (8.6-308) | |
| PTV diameter (median cm) (range) | 7.9 (3.7-20.54) | |
| PTV volume (median cc) (range) | 165.22 (27.3-453.6) | |
| Serum AFP (prior to SBRT) (mean ± SD) (ng/mL) | 7181.14 ± 17948 | P value = -0.049 |
| Serum AFP (3 months after SBRT) (mean ± SD) (ng/mL) | 2183.44 ± 7323 | |
- Citation: Khosla D, Gade VKV, Kapoor R, Singh G, Singh R, Taneja S, Premkumar M, Kalra N, De A, Bhujade H, Verma N, Duseja A, Gupta R. Stereotactic body radiation therapy in patients with unresectable hepatocellular carcinoma and portal vein tumor thrombosis. World J Hepatol 2025; 17(12): 110993
- URL: https://www.wjgnet.com/1948-5182/full/v17/i12/110993.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i12.110993